May 23, 2024 - Page 2 of 15

NYSE Companies - May 23, 2024

• Vince Tyra a quitté ses fonctions de président et chef de la direction• Fin du processus de vente MONTRÉAL, […]

NYSE Companies - May 23, 2024

Vince Tyra has Stepped Down as President and CEO Sale Process has Ceased MONTREAL, May 23, 2024 (GLOBE NEWSWIRE) — […]

CALGARY, Alberta, May 23, 2024 (GLOBE NEWSWIRE) — Acceleware® Ltd. (“Acceleware” or the “Company”) (TSX-V: AXE), a leading innovator of […]

CHS-114 shown to have an acceptable safety profile with no dose-limiting toxicities (DLTs) in heavily pretreated patients with solid tumors […]

MIAMI BEACH, Fla., May 23, 2024 (GLOBE NEWSWIRE) — In a release issued under the same headline earlier today by […]

MONTRÉAL, May 23, 2024 (GLOBE NEWSWIRE) — Premier Health of America Inc. (TSXV: PHA) (the “Corporation”), a leading Canadian Healthtech […]

ELI-002 7P administered as a monotherapy was well tolerated and able to generate a ~100x mKRAS-specific expanded T cell response […]

— KB-0742 continues to demonstrate a manageable safety and tolerability profile with no grade 3/4 neutropenia observed — — KB-0742 […]

– Results from pivotal Phase 2b ReNeu trial of mirdametinib in patients with NF1-PN to be presented in an oral […]

– Once every 3-week dosing of SNS-101 demonstrates initial signs of promising clinical activity – – Pharmacokinetic and safety profile […]